Industry
Six years after AIG bailout, trial asks: was it legal?
One of the more unusual trials to come out of the 2008 financial crisis is set to begin on Monday, when a federal judge will consider whether the U.S. government's rescue of American International Group Inc (AIG.N) was, in fact, legal.
Mercuria's third founder: China head eyes long game
The little known Asia head of Mercuria will be key in tying the Swiss commodity trader's $3.5 billion acquisition of JP Morgan Chase and Co's physical commodity desk into the company's China business.
Alibaba finance arm, Juneyao airline both get private bank approval
Alibaba Group Holding Ltd's finance arm has been given government approval to set up a private bank, China's banking regulator said on Monday, the latest step in the e-commerce company's push into the financial services sector.
Japan's Daiichi Sankyo to acquire US biopharma Ambit Biosciences
Japanese drugmaker Daiichi Sankyo Co Ltd (4568.T) has agreed to acquire U.S. biopharmaceutical company Ambit Biosciences Corp (AMBI.O) in a deal valued up to $410 million as it looks to build its presence in oncology, the companies said.




